FDD Leaders Handbook

Read more

Lynparza approved by US FDA

Read more

Lupin forays into OTC segment

Read more

Glenmark initiates Phase IIb dose range finding study

Read more

Intas acquires generics business of Actavis in UK, Ireland

Read more

Livongo and Lilly collaborate on real-world diabetes research

Read more

Eisai set-ups new OSD production facility in China

Read more

EU approves AstraZeneca’s Fasenra

Read more

Biogen and Eisai promote multiple sclerosis treatments in Japan

Read more

Novartis appoints Elizabeth Barrett as oncology head

Read more